Stocks
Funds
Screener
Sectors
Watchlists

Latest Blue Owl Capital Holdings LP Stock Portfolio

Blue Owl Capital Holdings LP Performance:
2025 Q3: 6.3%YTD: -11.32%2024: -2.99%

Performance for 2025 Q3 is 6.3%, and YTD is -11.32%, and 2024 is -2.99%.

About Blue Owl Capital Holdings LP and 13F Hedge Fund Stock Holdings

In it's latest 13F Holdings report, Blue Owl Capital Holdings LP reported an equity portfolio of $322.1 Millions as of 30 Sep, 2025.

The top stock holdings of Blue Owl Capital Holdings LP are , , . The fund has invested 13.2% of it's portfolio in NUVEEN CHURCHILL DIRECT LEND and 8.1% of portfolio in BLUE OWL CAPITAL CORPORATION.

The fund managers got completely rid off TOURMALINE BIO INC, IKENA ONCOLOGY INC (IKNA) and STARWOOD PPTY TR INC (STWD) stocks. They significantly reduced their stock positions in TANGO THERAPEUTICS INC (TNGX), MINERALYS THERAPEUTICS INC and CENTESSA PHARMACEUTICALS PLC (CNTA). Blue Owl Capital Holdings LP opened new stock positions in ROIVANT SCIENCES LTD (ROIV), IMAGENEBIO INC (IKNA) and IMMUNEERING CORP (IMRX). The fund showed a lot of confidence in some stocks as they added substantially to COMPASS PATHWAYS PLC (CMPS), DELL TECHNOLOGIES INC (DELL) and ULTRAGENYX PHARMACEUTICAL IN (RARE).

Blue Owl Capital Holdings LP Annual Return Estimates Vs S&P 500

Our best estimate is that Blue Owl Capital Holdings LP made a return of 6.3% in the last quarter. In trailing 12 months, it's portfolio return was -17.2%.

New Buys

Ticker$ Bought
roivant sciences ltd14,952,200
imagenebio inc4,408,530
immuneering corp3,850,000
nu hldgs ltd2,783,710
mereo biopharma group plc2,575,000
arcellx inc2,202,170
kalvista pharmaceuticals inc1,522,500
gitlab inc556,828

New stocks bought by Blue Owl Capital Holdings LP

Additions to existing portfolio by Blue Owl Capital Holdings LP

Reductions

Ticker% Reduced
tango therapeutics inc-85.34
mineralys therapeutics inc-69.95
servicetitan inc-56.35
centessa pharmaceuticals plc-48.74
rezolve ai plc-38.55
eyepoint pharmaceuticals inc-34.66
eledon pharmaceuticals inc-26.32
palvella therapeutics inc ne-23.95

Blue Owl Capital Holdings LP reduced stake in above stock

Sold off

Ticker$ Sold
biomea fusion inc-2,340,000
cabaletta bio inc-1,710,000
tourmaline bio inc-15,943,700
ikena oncology inc-5,482,100
rezolve ai plc-558,626
starwood ppty tr inc-2,638,420
tempus ai inc-5,093,810
apogee therapeutics inc-1,520,050

Blue Owl Capital Holdings LP got rid off the above stocks

Sector Distribution

Blue Owl Capital Holdings LP has about 40.3% of it's holdings in Others sector.

Sector%
Others40.3
Healthcare40.3
Technology12.1
Consumer Cyclical4.7
Industrials2.3

Market Cap. Distribution

Blue Owl Capital Holdings LP has about 2.7% of it's portfolio invested in the large-cap and mega-cap stocks.

Category%
UNALLOCATED42
SMALL-CAP29.7
MID-CAP15.2
MICRO-CAP9.1
LARGE-CAP2.7
NANO-CAP1.3

Stocks belong to which Index?

About 34.7% of the stocks held by Blue Owl Capital Holdings LP either belong to S&P 500 or RUSSELL 2000 index.

Index%
Others65.2
RUSSELL 200034.7
Top 5 Winners (%)%
PGY
pagaya technologies ltd
198.6 %
CNTA
centessa pharmaceuticals plc
84.5 %
TNGX
tango therapeutics inc
64.1 %
EYPT
eyepoint pharmaceuticals inc
51.3 %
ADCT
adc therapeutics sa
49.3 %
Top 5 Winners ($)$
HLLY
holley inc
4.7 M
CNTA
centessa pharmaceuticals plc
3.7 M
EYPT
eyepoint pharmaceuticals inc
2.7 M
TNGX
tango therapeutics inc
2.7 M
CMPX
compass therapeutics inc
2.3 M
Top 5 Losers (%)%
VRNA
verona pharma plc
-100.0 %
BKSY
blacksky technology inc
-43.0 %
MRKR
marker therapeutics inc
-41.7 %
DAVE
dave inc
-40.1 %
CGEM
cullinan therapeutics inc
-20.4 %
Top 5 Losers ($)$
CGEM
cullinan therapeutics inc
-3.8 M
VRNA
verona pharma plc
-1.7 M
RARE
ultragenyx pharmaceutical in
-1.6 M
MRKR
marker therapeutics inc
-0.4 M
ELDN
eledon pharmaceuticals inc
-0.2 M

Blue Owl Capital Holdings LP Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Blue Owl Capital Holdings LP

Blue Owl Capital Holdings LP has 72 stocks in it's portfolio. About 61.7% of the portfolio is in top 10 stocks. CGEM proved to be the most loss making stock for the portfolio. HLLY was the most profitable stock for Blue Owl Capital Holdings LP last quarter.

Last Reported on: 12 Nov, 2025
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions